The PCM4EU consortium on 28 April 2025 organized a 90 min open workshop during the Nordic Precision Medicine Forum in Stockholm, Sweden. Here, the first PCM4EU Report on Precision Cancer Medicine Implementation in different European countries, “State of the Union of precision medicine implementation in cancer 2025 report”, was launched. This report provides a snapshot of the implementation efforts in personalised cancer medicine in different EU member states as of April 2025. Altogether, 19 European countries are included in the report also attached below.

A panel discussion entitled “What is next in PCM implementation” followed the launch of the report. The panel members included

·      Hans Gelderblom, Professor, Medical Oncologist,Leiden University Medical Center, The Netherlands and coordinator of PCM4EU

·      Kjetil Taskén, Professor, Head Institute for CancerResearch & Director, Centre for Precision Cancer Medicine, Oslo UniversityHospital Comprehensive Cancer Centre

·      Ebba Hallersjö Hult, Co-founder Testbed SwedenPrecision Health Cancer, Stockholm School of Economics Institute for Research

·      Panel Moderator Bettina Ryll, Founder, MPNEurope,Subject matter expert Personalised Medicine and Patient-Centric Innovation,Nollvision cancer

‍